Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Revisiting the Human Sweat Gland - Does Arginine Vasopressin Modulate Sweat Sodium Concentration Via the V2 Receptor?

NCT02084797 is registered in ClinicalTrials.gov with Oakland University as lead sponsor.

NCT NCT02084797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Revisiting the Human Sweat Gland - Does Arginine Vasopressin Modulate Sweat Sodium Concentration Via the V2 Receptor?
Lead sponsor
Oakland University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
October 31, 2012
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electrolyte imbalance, hypernatremia, hyponatremia